CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
OPERATING ACTIVITIES
Net income	$ 899.8	$ 622.0	$ 2,592.4	$ 1,987.5
Adjustments to reconcile net earnings to net cash provided from operating activities:
Depreciation, amortization and depletion	213.1	212.5	631.7	625.4
Equity earnings (loss) of affiliate, net of dividends received	0.5	0.1	(5.9)	10.7
(Gain) loss on foreign currency transaction effect	18.1	(7.4)	13.8	3.7
(Benefit) provision for deferred income taxes	(25.5)	(49.6)	(2.4)	(43.3)
Other, net	3.2	7.2	14.3	21.7
Change in operating assets and liabilities:
(Increase) / decrease in accounts receivable	92.0	(63.1)	(389.1)	263.1
(Increase) / decrease in inventories	29.4	(2.4)	4.5	13.2
Increase / (decrease) in accounts payable and accrued liabilities	22.6	226.5	28.7	53.8
Decrease / (increase) in other operating assets and liabilities	186.2	104.0	173.1	96.3
Net cash provided by operating activities	1,439.4	1,049.8	3,061.2	3,032.1
INVESTING ACTIVITIES
Capital expenditures	(246.4)	(262.7)	(792.0)	(753.2)
(Purchase) / proceeds from sale of short-term investments, net	10.3	(246.8)	280.5	(38.8)
Other		0.5		0.6
Net cash (used in) provided by investing activities	(236.0)	(509.0)	(511.5)	(791.4)
FINANCING ACTIVITIES
Cash dividends paid to common stockholders	(468.8)	(773.1)	(1,087.3)	(2,319.3)
Other, net	(2.3)	(2.0)	(3.9)	(6.4)
Net cash (used in) financing activities	(471.0)	(775.1)	(1,091.2)	(2,325.7)
Effect of exchange rate changes on cash and cash equivalents	47.1	2.4	44.7	(17.6)
(Decrease) / increase in cash and cash equivalents	779.5	(231.9)	1,503.3	(102.6)
Cash and cash equivalents, at beginning of period	1,875.3	2,199.0	1,151.5	2,069.7
Cash and cash equivalents, at end of period	$ 2,654.8	$ 1,967.1	$ 2,654.8	$ 1,967.1